Amoy Diagnostics Co., Ltd. (SHE:300685)
19.55
+0.33 (1.72%)
May 19, 2026, 10:15 AM CST
Amoy Diagnostics Market Cap
Amoy Diagnostics has a market cap or net worth of 7.41 billion as of May 18, 2026. Its market cap has decreased by -7.11% in one year.
Market Cap
7.41B
Enterprise Value
6.18B
Revenue
1.19B
Ranking
n/a
PE Ratio
21.59
Stock Price
19.55
Market Cap Chart
Since August 2, 2017, Amoy Diagnostics's market cap has increased from 1.60B to 7.41B, an increase of 364.30%. That is a compound annual growth rate of 19.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 7.41B | -6.33% |
| Dec 31, 2025 | 7.92B | -11.84% |
| Dec 31, 2024 | 8.98B | 3.50% |
| Dec 29, 2023 | 8.67B | -17.63% |
| Dec 30, 2022 | 10.53B | -37.10% |
| Dec 31, 2021 | 16.74B | -3.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 2, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BGI Genomics | 15.64B |
| Guangzhou Kingmed Diagnostics Group | 12.04B |
| Dian Diagnostics Group | 11.45B |
| Shanghai Runda Medical Technology | 7.99B |
| Beijing Strong Biotechnologies,Inc. | 7.64B |
| Maccura Biotechnology Co.Ltd | 6.25B |
| Cowealth Medical China | 5.76B |
| Thalys Medical Technology Group | 4.47B |